Skip to main content

Mirar mientras lo inyectan ayuda a reducir el dolor




Jeringa
Eso concluyó estudio adelantado por las universidades de Londres y de Milán-Bicocca.


Por: Redacción eltiempo.com | 4:52 p.m. | 10 de Febrero del 2011La investigacíón encontró que cuando una persona mira mientras recibe una inyección o le sacan una muestra de sangre, resulta menos doloroso para ella que cerrar los ojos o apartar la vista.

Los investigadores, cuyo trabajo acaba de ser publicado en 'Psychological Science', sostienen que este hallazgo aporta claves sobre cómo el cerebro procesa el dolor. Sugieren, además, que una mejor comprensión de este mecanismo podría conducir a nuevos tratamientos para algunas enfermedades crónicas.

Según los autores del estudio, se aplicó una sonda de calor en la mano a 18 voluntarios y se aumentó gradualmente la temperatura. Tan pronto como la persona empezó a sentir dolor, la sonda se retiró y se midió la temperatura.

Patrick Haggard, profesor de neurociencia cognitiva de la Universidad de Londres, explicó que "esto nos da una medida del umbral de dolor, y es una manera segura y fiable de medir cuándo las vías cerebrales que ponen de manifiesto el dolor se activan".

También se utilizó un conjunto de espejos para manipular lo que los voluntarios veían. De este modo se estableció que aquellos que veían su mano en el espejo podían tolerar, en promedio, 3 grados centígrados más de calor, que aquellos cuya mano estaba oculta por un bloque de madera.

Citado por BBC Ciencia, Haggard señaló que "siempre les aconsejo a los niños que no miren cuando están recibiendo una inyección o se les toma una muestra de sangre, pero hemos descubierto que mirar el cuerpo es analgésico: sólo mirarlo reduce los niveles de dolor".

Comments

Popular posts from this blog

Nordic Walking Benefits, ADHD and Diet, Supplements and Cancer, Sources of Fiber

A Better Way To Walk: Nordic Walking Improves Quality of Life, Depression, and Functional Capacity SciTechDaily Reference: “Sustained Effects of Different Exercise Modalities on Physical and Mental Health in Patients With Coronary Artery Disease: A Randomized ... Dietary Interventions for ADHD: Emerging Research and Considerations There has been increasing interest in the role that diet and supplements play in the treatment of attention-deficit/hyperactivity disorder (ADHD) symptoms, from patients and researchers alike. Diet is an important treatment approach to consider, as it is a lifestyle change rather than a medication. Additionally, at least 10% to 30% of children with ADHD are non-responsive to, or experience adverse effects from, ADHD medications­­­­.1 A dietary approach to ADHD can be complementary to a conventional pharmacological approach, giving patients and their families more options toward a personalized treatment plan. This article will examine current research about di

More People Are Microdosing for Mental Health. But Does It Work?

By Dana G Smith. Joseph started microdosing psychedelics five years ago to try to improve his mental health. “I was just kind of in this depression, in this rut,” he said. “I was unhappy and angry and agitated all the time, and it went against the way that I saw myself.” Depression and anxiety run in Joseph’s family, and he’d been prescribed Prozac as a kid. But when symptoms of depression returned in his early 30s, he didn’t want to go back to a prescription drug. Joseph, an Austin-based designer (he asked to withhold his full name, citing privacy concerns surrounding mental health issues and illegal drug use), came across research from Johns Hopkins University about psilocybin, the active ingredient in hallucinogenic, or “magic,” mushrooms. In a small study, full doses of the drug helped cancer patients cope with depression and anxiety. Then he read anecdotes of Silicon Valley influencers claiming increased energy from taking tiny doses of psychedelics. So he decided to start microdo

Exploring the Link Between Circadian Rhythms, Longevity, and Wearable Data: Insights and Future Directions

A recent study in NHANES 2011–2014 explores the potential connection between disruptions in circadian rhythms, measured using wearable devices, and their impact on health outcomes and longevity. The study analyzes data from 7,297 U.S. adults collected through wearable accelerometers as a novel digital biomarker for longevity. Five distinct clusters were identified based on activity profiles: "High activity," "Low activity," "Mild circadian rhythm (CR) disruption," "Severe CR disruption," and "Very low activity." The findings reveal that young adults with extreme circadian rhythm disturbance exhibit higher white blood cell counts and accelerated biological aging. Older adults with circadian disruption are associated with increased systemic inflammation indexes, advanced biological aging, and higher all-cause mortality risk. The research underscores the importance of circadian alignment for longevity at all ages and suggests that wearable